- Home
- BIVI vs LSB Comparison
BIVI vs LSB Comparison
Compare BIVI & LSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIVI
- LSB
- Stock Information
- Founded
- BIVI 2013
- LSB 2002
- Country
- BIVI United States
- LSB China
- Employees
- BIVI N/A
- LSB N/A
- Industry
- BIVI Biotechnology: Pharmaceutical Preparations
- LSB
- Sector
- BIVI Health Care
- LSB
- Exchange
- BIVI Nasdaq
- LSB NYSE
- Market Cap
- BIVI 49.8M
- LSB 53.6M
- IPO Year
- BIVI N/A
- LSB N/A
- Fundamental
- Price
- BIVI $1.48
- LSB $2.23
- Analyst Decision
- BIVI Strong Buy
- LSB
- Analyst Count
- BIVI 1
- LSB 0
- Target Price
- BIVI $30.00
- LSB N/A
- AVG Volume (30 Days)
- BIVI 596.3K
- LSB 7.4K
- Earning Date
- BIVI 02-11-2025
- LSB 12-19-2024
- Dividend Yield
- BIVI N/A
- LSB N/A
- EPS Growth
- BIVI N/A
- LSB N/A
- EPS
- BIVI N/A
- LSB N/A
- Revenue
- BIVI N/A
- LSB $79,415,311.00
- Revenue This Year
- BIVI N/A
- LSB $39.33
- Revenue Next Year
- BIVI N/A
- LSB $75.61
- P/E Ratio
- BIVI N/A
- LSB N/A
- Revenue Growth
- BIVI N/A
- LSB N/A
- 52 Week Low
- BIVI $1.04
- LSB $1.88
- 52 Week High
- BIVI $33.10
- LSB $11.20
- Technical
- Relative Strength Index (RSI)
- BIVI 32.72
- LSB 40.56
- Support Level
- BIVI $1.45
- LSB $2.10
- Resistance Level
- BIVI $1.88
- LSB $2.49
- Average True Range (ATR)
- BIVI 0.16
- LSB 0.22
- MACD
- BIVI -0.01
- LSB 0.00
- Stochastic Oscillator
- BIVI 5.08
- LSB 16.35
About BIVI BioVie Inc.
BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.
About LSB LAKESHORE BIOPHARMA CO LTD
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.